Author Archive: Doug Mcvay

In Memoriam: Jacki Rickert

Follow Us!Share This!Longtime medical cannabis advocate Jacki Rickert sadly passed away on December 26, 2017. She will be sorely missed. Her good friend and fellow Wisconsin activist Gary Storck wrote this moving tribute to her, Remembering Wisconsin Medical Cannabis Advocate Jacki Rickert 1951-2017. Follow Us!Share This!

Medical Cannabis

Cannabis Use by Pregnant Women

Follow Us!Share This!Researchers from Kaiser Permanente Northern California wrote a research letter published in the Journal of the American Medical Association on December 26, 2017, Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016. The researchers found: “From 2009 through 2016, the adjusted prevalence of prenatal marijuana use based on self-report or toxicology increased from 4.2% (95% CI, 4.0%-4.5%) to 7.1% (95% CI, 6.7%-7.5%) and was higher based on toxicology than selfreport each year…
Read more

Cannabis Research, Pregnancy

, , ,

Patients Out of Time Coming to Canada in 2018!

Follow Us!Share This!Co-founder and President of Patients Out of Time Mary Lynn Mathre, RN, MSN, CARN, will be making several stops across Canada in early 2018 to present educational workshops for nurses and nurse practitioners. The workshops are hosted and organized by Executive Links through their healthcare branch, Nursing Links. Here’s what Mary Lynn had to say about the first set of these events, which were held in late 2017: It was such an honor and a pleasure to be…
Read more

Medical Cannabis

Tell The Attorney General: Obey The Law

Follow Us!Share This!Bryan Krumm is a psychiatric nurse practitioner and medical cannabis patient advocate in New Mexico. He’s spoken at some of our conferences, so you may be familiar with him and the great work he does. Recently, Bryan started a petition at that you’ll want to know about, and should consider signing. In 2009, Bryan Krumm filed a rescheduling petition for Cannabis with the DEA. Last year the DEA settled that rescheduling petition and agreed to stop blocking…
Read more

Medical Cannabis

Legal Medical Cannabis Displacing Alcohol Use?

Follow Us!Share This!The impact of medical cannabis on prescription drug use is becoming well known. Research presented at the Eleventh National Clinical Conference on Cannabis Therapeutics showed that the legal availability of medical cannabis has led many people to reduce their use of opioids and other prescribed medications, and also that the number of prescriptions being written for opioids, anti-depressants, sleeping pills, and some other medications appears to have declined in states with medical marijuana laws. So what about the…
Read more

Alcohol, News, Public Policy

House Votes To Keep Medical Cannabis Protections In Place Until Dec 22

Follow Us!Share This!The US House of Representatives on Thursday, Dec. 7, 2017, voted to keep protections in place that prevent the Department of Justice from going after state-legal medical cannabis businesses. The bill they approved is not the annual appropriations bill, rather it is a continuing resolution that only keeps the federal government funded and operating through December 22. The Rohrabacher-Blumenauer Amendment is a “rider” that was added to the Commerce, Justice Science, and Related Agencies appropriations legislation. That bill…
Read more

Cannabis Industry, News, Public Policy, State Laws

Medical Cannabis as a Substitute for Prescription Drugs

Follow Us!Share This!Evidence continues to mount that medical cannabis is a viable substitute for several types of prescription medication, including opioid painkillers, anti-anxiety drugs, and sleeping medications. In November 2017, the journal PLOS One published research results out of the New Mexico Medical Marijuana Program (“Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study“) that found “a strong correlation between enrollment in an MCP and cessation or reduction of opioid use. From a…
Read more

Cannabis Research, Continuing Education Seminar, Medical Cannabis, National Clinical Conference, Opioids and Other Prescription Drugs, Public Policy, Therapeutic Effects

FDA Sends Warning Letters To CBD Companies About Health Claims

Follow Us!Share This!On October 31, the US Food and Drug Administration sent warning letters to several companies involved in selling products that are reported to contain CBD, over health claims being made by the sellers about their products. According to the FDA: The FDA has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that…
Read more

Cannabis Industry, News, Public Policy

, ,